Clinical Trials Browser

ixazomib × Lymphoid × 90 days × Clear all

NCT03547700 2026-05-06

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Phase 1/2 Terminated

11 enrolled 10 charts

Lymphoma, T-Cell, Peripheral

NCT03506373 2026-05-05

Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia

Phase 2 Terminated

21 enrolled 11 charts

Waldenstrom Macroglobulinemia